|
시장보고서
상품코드
2075923
반려동물 관절염 시장 : 동물 유형별, 적응증별, 치료법별, 유통 채널별, 지역별Companion Animal Arthritis Market, By Animal Type, By Indication, By Treatment, By Distribution Channel, By Geography |
||||||
반려동물 관절염 시장은 2026년에 50억 3,000만 달러 규모에 이를 것으로 추정되며, 2033년까지 85억 2,000만 달러에 이를 것으로 예상되고 있습니다. 2026-2033년 CAGR 7.8%로 성장할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 시장 규모(2026년) : | 50억 3,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간 CAGR(2026-2033년) : | 7.80% | 시장 규모 예측(2033년) : | 85억 2,000만 달러 |
퇴행성 관절염(OA)은 개와 고양이에게 흔히 나타나는 질환입니다. 이는 경미한 염증을 동반하는 진행성 퇴행성 관절 질환으로 특징지어집니다. OA는 연골하 뼈의 대사 변화, 골극 형성, 그리고 활막의 염증과 관련되어 관절 연골의 변성 및 비정상적인 회복에 의해 유발됩니다. 반려동물의 경우, 골관절염은 거의 항상 관절 이완, 골연골증, 외상 등의 기저 질환에 이차적으로 발생합니다. 이는 관절낭의 섬유화 및 골막 반응을 동반하는 병리학적 과정으로, 보행 양상과 가동 범위의 변화를 초래합니다. 그 결과, 근골격계와 이차적인 관절 안정 기전이 손상되어, 비정상적인 부하와 마모로 인해 관절 연골이 더욱 악화되게 됩니다.
시장 역학 :
세계의 반려동물용 관절염 치료제 시장은 주로 신약 개발이 진행되고 있는 것이 성장 동력이 되고 있습니다. 예를 들어, 캐나다 보건 연구소(CIHR)는 2021년에 시작된 60만 달러 규모의 컴퓨터 지원 설계(CAD) 프로젝트에 자금을 지원했습니다. 이 프로젝트는 개의 퇴행성 관절염 치료에 있어 중간엽 줄기세포의 효능을 평가하는 데 중점을 두고 있습니다. 이 연구에서는 팔꿈치 관절 또는 무릎 관절에 퇴행성 관절염을 앓고 있는 반려견을 대상으로 한 무작위 배정 이중 맹검 위약 대조 임상시험이 진행되고 있습니다(출처 : CIHR 프로젝트 자금 지원). 이러한 연구를 통해 얻은 인사이트는 새로운 재생의학 치료 옵션이 지닌 가능성에 대해 귀중한 시사점을 제공할 것으로 기대됩니다. 또한, 첨단 치료법의 선택지가 늘어남에 따라 더 많은 반려동물 주인들이 수의사의 도움을 받아 반려동물의 관절염을 적극적으로 관리하게 될 것입니다. 그 결과, 반려동물의 관절염 시장은 당분간 지속적인 성장을 이어갈 것으로 보입니다.
본 조사의 주요 특징 :
- 본 조사는 다양한 부문에서 잠재적인 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스를 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트도 제공합니다.
- 본 조사에서는 다음의 매개변수(기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략)를 바탕으로 세계 반려동물 관절염 시장의 주요 업체들을 분석했습니다.
- 본 보고서를 통해 얻은 인사이트를 바탕으로, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 대해 정보에 입각한 의사결정을 내릴 수 있게 됩니다.
- 이 책 '세계 반려동물용 관절염 치료제 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계의 반려동물 관절염 시장 분석에 활용된 다양한 전략 매트릭스를 활용함으로써 의사결정을 원활하게 진행할 수 있을 것입니다.
목차
제1장 조사 목적 및 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 반려동물 관절염 시장 : 동물 유형별(2021-2033년)
제5장 세계의 반려동물 관절염 시장 : 적응증별(2021-2033년)
제6장 세계의 반려동물 관절염 시장 : 치료별(2021-2033년)
제7장 세계의 반려동물 관절염 시장 : 유통 채널별(2021-2033년)
제8장 세계의 반려동물 관절염 시장 : 지역별(2021-2033년)
제9장 경쟁 구도
제10장 섹션
AJY 26.07.09Companion Animal Arthritis Market is estimated to be valued at USD 5.03 Bn in 2026 and is expected to reach USD 8.52 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7.8% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 5.03 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 7.80% | 2033 Value Projection: | USD 8.52 Bn |
Osteoarthritis (OA) is a common condition that affects dogs and cats. It is characterized as a low-grade inflammatory, progressive degenerative joint disease. OA results from degeneration and aberrant repair of articular cartilage in association with alterations in subchondral bone metabolism, osteophytosis, and synovial inflammation. In companion animals, OA is almost always secondary to an underlying abnormality, such as joint laxity, osteochondrosis, trauma, etc. It is a pathological process that includes joint capsule fibrosis and periosteal reactions, leading to an altered gait and range of motion. In turn, there is a deterioration of the musculoskeletal system and secondary joint stabilizers, resulting in further deterioration of articular cartilage due to abnormal loading and wear.
Market Dynamics:
The global companion animal arthritis market is mainly driven by the increasing development of novel therapeutics. For instance, the Canadian Institutes of Health Research (CIHR) funded a US$600,000 Computer-aided design (CAD) project launched in 2021 focused on evaluating the efficacy of mesenchymal stem cells for the treatment of osteoarthritis in dogs. The study involves a randomized, double-blinded, placebo-controlled clinical trial involving client-owned dogs with elbow or stifle osteoarthritis (source: CIHR project funding). Findings from these studies will provide valuable insights into the potential of new regenerative medicine options. Furthermore, the greater availability of advanced treatment choices will encourage more pet owners to actively manage their pet's arthritis with the help of veterinarians. This, in turn, will fuel ongoing expansion in the companion animal arthritis market beyond the foreseeable future.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global companion animal arthritis market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Vetoquinol, NexGen Pharmaceuticals, Norbrook, Eltech K-Laser s.r.l, Zoetis, Virbac, Elanco, Boehringer Ingelheim International GmbH, Ceva, Dechra Pharmaceuticals PLC .
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global companion animal arthritis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global companion animal arthritis market
Global Companion animal arthritis Market Detailed Segmentation:
- By Animal Type (Revenue, USD Bn, 2021 - 2033)
- Dogs
- Cats
- Others
- By Indication (Revenue, USD Bn, 2021 - 2033)
- Osteoarthritis
- Other Arthritis
- By Treatment (Revenue, USD Bn, 2021 - 2033)
- Medication
- NSAIDs
- Monoclonal Antibodies
- Others Medications
- Supplements
- Other Treatment
- By Distribution Channel (Revenue, USD Bn, 2021 - 2033)
- Veterinary Hospitals & Clinics
- Retail Pharmacies
- Online Stores
- Others
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Global Companion animal arthritis Market, Key Players
- Vetoquinol
- NexGen Pharmaceuticals
- Norbrook
- Eltech K-Laser s.r.l
- Zoetis
- Virbac
- Elanco
- Boehringer Ingelheim International GmbH
- Ceva
- Dechra Pharmaceuticals PLC
- Others Prominent Players .
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Companion Animal Arthritis Market, By Animal Type
- Global Companion Animal Arthritis Market, By Treatment
- Global Companion Animal Arthritis Market, By Indication
- Global Companion Animal Arthritis Market, By Distribution Channel
- Global Companion Animal Arthritis Market, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Rising Concerns About Self-Image and Confidence
- Side effects of treatment options
- Untapped emerging markets
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Service offering Portfolio
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Pipeline Analysis
4. Global Companion Animal Arthritis Market, By Animal Type, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Dogs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Cats
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
5. Global Companion Animal Arthritis Market, By Indication, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Osteoarthritis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Other Arthritis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
6. Global Companion Animal Arthritis Market, By Treatment, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Medication
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- NSAIDs
- Monoclonal Antibodies
- Others Medications
- Supplements
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Other Treatments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
7. Global Companion Animal Arthritis Market, By Distribution Channel, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Veterinary Hospitals & Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Online Stores
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
8. Global Companion Animal Arthritis Market, By Region, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, By Country, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Country 2022 -2033
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033,(US$ Bn)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Vetoquinol
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- NexGen Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Norbrook
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Eltech K-Laser s.r.l
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Zoetis
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Virbac
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Elanco
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Boehringer Ingelheim International GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Ceva
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Dechra Pharmaceuticals PLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Others Prominent Players
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
10. Section
- Research Methodology
- About us
